Form D · Other
Valkyrie Sciences Holdings LLC
Austin, TX · CIK 0002107816
Offering snapshot reported Mar 6, 2026 · SEC filing
- Reported sold
- $9.09M Offering amount: $12.5M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2026 | Initial | $9,090,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $60K
- Form D file number
- 021-575650
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| ThinkEquity LLC | 20996 |
Source: Form D, filed Mar 6, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Burgoyne | Director |
| Elizabeth Coufal | Director |
| Jason Paull | Director |
Issuer details
Industry: Other (See others in industry)
Address:
515 Congress Ave. Ste. 1425
Austin, TX, 78701
Austin, TX, 78701